[1] Xiao M,Sha L,Li Y et al.Gut microbiota’s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics.Nutrients,2018,10, 1457-1478.
[2] 张真玲,段志军.肠肝轴-肝病防治中的重要目标.世界华人消化杂志,2016,24:3454-3460.
[3] Milosevic I,Vujovic A, Barac A et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature.Int.J.Mol.Sci,2019,20:395-411.
[4] Lin SL,Wang ZY,Lam KL et al. Role of intestinal microecology in the regulation ofenergy metabolism by dietary polyphenols and their metabolites. Food Nutr Res,2019,63:1518-1530.
[5] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19:389-400.
[6] Yang RL,Xu Y,Dai ZF et al.The Immunologic role of gut microbiota in patients with chronic HBV infection.J Immunol Res,2018,1:1-6.
[7] Sarangi AN,Goel A,Singh A et al. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose admini-stration.BMC Gastroenterol,2017,17:125-137.
[8] Usami M,Miyoshi M,Yamashita M.Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol,2015,21:11597-11608.
[9] Betrapally NS,Gillevet PM,Bajaj JM et al.Gut microbiome and liver disease.Trasl Res,2017,179:49-59.
[10] 董敏,张小强,乔亚琴等.肝硬化与肠道微生态失衡研究进展.肝脏,2018,23:446-451.
[11] Dubinkina VB,Tyakht AV,Odintsova VY et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome, 2017,5:141-155.
[12] Liang S,Wu XL,Jin F. Gut-brain psychology: rethinking psychology from the microbiota-gut-brain axis.Front Integr Neurosci,2018,12:1-24.
[13] Rai RH, Sarasmat VA,Dhiman RK.Gut microbiota:its role in hepatic encephalopathy.J Clin Exp Hepatol,2015,5:29-36.
[14] Bajaj JS.The role of microbiota in hepatic encephalopathy.Gut Microbes,2014,5:397-403.
[15] Bajaj JS,Betrapally NS,Hylemon PB et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology,2015,62: 1260-1271.
[16] Mindikoglu AL, Pappas SC. New developments in hepatorenal syndrome. Clin Gastroenterol Hepatol,2018,16:162-177.
[17] Bucsics T,Krones E.Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.Gastroenterol Rep(Oxf),2017,5:127-137.
[18] Bajaj JS, Heuman DM, Hylemon PB, et al.Altered profile of human gut microbiome is associated with cirrhosis and its complications.J Hepatol,2014,60:940-947.
[19] Fukui H. Gut microbiome-based therapeutics in liver cirrhosis: basic consideration for the Next Step.J Clin Transl Hepatol,2017,5:249-260.
[20] Bajaj JS,Kassam Z,Fagan A et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology,2017,66:1727-1738.
[21] Heath RD,Cockerell C,Mankoo R et al. Fecal microbiota transplantation and its potential therapeutic uses in gastro-intestinal disorders. North Clin Istanb ,2018,5:79-88.
[22] 田威.健康幼儿大便悬液灌肠治疗肠道菌群失调1例.世界最新医学信息文摘,2018,18: 187.
[23] Zhang FM,Cui BT,He XX et al.Microbiota transplantation: concept,methodology and strategy for its modernization.Protein Cell,2018,9:462-473. |
